28 Jul 2026Open access
Integrated biomarkers of oxidative stress NLRP3 inflammasome and kynurenine pathway reflect disease severity and diagnostic discrimination in depressionPublisher siteScientific Reports, Tryptophan and brain disorders
UniversitiesNashwa Eltantawy
Active, last published 2026
In inflammasome and immune disorders
Nashwa
Eltantawy
Scholar“Research focused on Inflammasome and immune disorders and adjacent fields.”
Egyptian Russian University
Claim Your Profile4
H-index
39
Citations
Nashwa has not officially claimed their profile. If you are Nashwa, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ashwa Eltantawy is a researcher working on Inflammasome and immune disorders. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Nashwa's work has been cited 39 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Inflammasome and immune disorders×2Parkinson's Disease Mechanisms and Treatments×2Inflammatory Bowel Disease×2Acne and Rosacea Treatments and Effects×2
04 · Where I am
Affiliations
Affiliation on published researchEgyptian Russian UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
8 works1 Apr 2026Open access
Immunomodulatory and Anti-Inflammatory Effects of Ketotifen Versus Vitamin E in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Pilot StudyPublisher siteDrug Design Development and Therapy, Liver Disease Diagnosis and Treatment
30 Mar 2026Open access
Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot TrialPublisher sitePharmaceuticals, Inflammatory Bowel Disease
12 Jan 2026Open access
Interplay of oxidative stress and Inflammasome activation and clinical indices in Parkinson’s disease: insights from serum SIRT1, Nrf2, and NLRP3 levels and PDQ-39—a cross-sectional studyPublisher siteFrontiers in Neuroscience, Parkinson's Disease Mechanisms and Treatments
2 May 2025Open access8cites
Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson’s diseasePublisher siteFrontiers in Pharmacology, Parkinson's Disease Mechanisms and Treatments
29 Nov 2024Open access8cites
Antimicrobial Stewardship Intervention for the Family Caregiver Attending Primary Health Care Setting: A Quasi-Experimental StudyPublisher siteAntibiotics, Antibiotic Use and Resistance
1 Nov 2024Open access12cites
Fenofibrate as an Adjunct Therapy for Ulcerative Colitis: Targeting Inflammation via SIRT1, NLRP3, and AMPK Pathways: A Randomized Controlled Pilot StudyPublisher siteDrug Design Development and Therapy, Inflammatory Bowel Disease
24 Jun 2024Open access1cites
Correlation between depression scores and serum <scp>NF</scp>‐<scp>ĸB</scp>/<scp>NLRP3</scp> axis, biotinidase, and <scp>HMGB1</scp> after treatment with isotretinoin in patients with acne vulgarisPublisher siteJournal of Cosmetic Dermatology, Acne and Rosacea Treatments and Effects
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Nashwa?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you